In 2023, Doug Ingram earned $1.68M in total compensation at Sarepta Therapeutics, Inc., including $814.03K salary and $842.52K bonus. Most recently acquired 76,792 shares in Feb 2025. Currently holds stock worth $8.88M. 9+ years at the helm of Sarepta Therapeutics, Inc..
Compensation History
Annual executive compensation data for Doug Ingram, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.68M
Salary
$814.03K
Bonus
$842.52K
Other
$19.02K
Salary
$814.03KBoard Justification
The compensation program aims to attract and retain qualified executives, motivate performance, and align interests with stockholders through competitive pay and performance-based incentives.
Bonus
$842.52KBoard Justification
Performance-based cash payment based on achievement of 2023 corporate goals, resulting in 115% of target bonus.
Other Compensation
$19.02KBoard Justification
Includes matching contributions to 401(k) account and long-term disability premiums.
Restricted Stock
Board Justification
No stock awards were granted or vested in 2023.
Performance Metrics
Performance metrics for 2023 included product revenue goals and achieving regulatory milestones.
Doug Ingram
CEO of Sarepta Therapeutics, Inc.
Education
MBA from the Wharton School of the University of Pennsylvania
Field of Expertise
Healthcare & Life Sciences - Pharmaceuticals
Sector of Economy
Healthcare
Born
January 1, 1972 - 53 years ago
CEO of Sarepta Therapeutics, Inc. for
9 years 6 months (Jun 2016 - Present)
Previous Experience
President of the North America region at Celgene Corporation
Other Sarepta Therapeutics, Inc. CEOs
Holdings
Track Doug Ingram's stock holdings and portfolio value over time.
Insider Trading
Doug Ingram's recent stock transactions, purchases, and sales filed with the SEC.
$2.02M
SRPT at $79.96/share
Nov 3, 2023
Purchase
$2.00M
SRPT at $79.94/share
Nov 17, 2021
Purchase
$2.00M
SRPT at $123.09/share
Aug 12, 2019
Purchase
$2.01M
SRPT at $120.60/share
Oct 30, 2018
Purchase
$2.00M
SRPT at $125.26/share
Aug 15, 2018
Purchase
$2.00M
SRPT at $52.44/share
Nov 8, 2017
Purchase
$2.00M
SRPT at $42.50/share
Jul 27, 2017
Purchase
335,000 shares
SRPT
Jun 26, 2017
Received
Rivals
Compare Doug Ingram with competitor CEOs and industry peers.